Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Somatus and Anthem, Inc. Collaborate to Deliver Personalized, Value-Based Kidney Care

11/03/2021 | 07:08am EST

Nationwide partnership is strengthened by Anthem’s investment in Somatus, supporting the successful expansion of its kidney care model and technology platform

Somatus, a market leader in value-based kidney care, today announced a long-term, multi-year partnership with Anthem, Inc (NYSE: ANTM). Together, Anthem and Somatus will change how kidney care is experienced and delivered for members of Anthem’s affiliated Medicare Advantage plans, specifically individuals with chronic kidney disease (CKD) Stage 3, 4, and 5 and end-stage kidney disease (ESKD). Somatus’ services are available to eligible CKD and ESKD members enrolled in Anthem-affiliated Medicare Advantage plans starting on November 1, 2021, and ESKD Chronic Special Needs Plans starting on January 1, 2022. In addition to this partnership, Anthem made a strategic investment in Somatus.

Somatus’ partnership with Anthem expands the Company’s geographic footprint to 34 states and increases its kidney care lives under management to more than 150,000. The Company is currently partnered with 10 national and regional health plans, several dozen hospitals and health systems, and more than 19,000 primary care providers, nephrologists, and other specialists. The Company’s impressive growth across all kidney care stakeholders reflects its demonstrated ability to improve quality of care and lower costs for patients with kidney disease.

“Anthem is committed to providing access to innovative programs that meet each health plan member’s unique healthcare needs,” said Elena McFann, President of Anthem’s Medicare business. “Investing in and partnering with Somatus ensures consumers with kidney disease enrolled in our affiliated health plans will receive industry-leading personalized, in-home care and resources they need to improve their health and wellbeing.”

As part of this collaboration, Anthem will enable bi-directional data exchange with Somatus via Anthem’s Health OS, which is a comprehensive, cloud native, payor and provider agnostic platform for health that connects siloed health data and disparate technologies to drive deeper insights as well as reduce costs and complexity. The secure, bi-directional data exchange will transmit timely alerts on member admission and discharge to optimize care, simplify coordination with Anthem care management personnel, and enhance the consumer and provider experience.

“Through this national partnership with Anthem and support from both local and community-based providers, Somatus’ reach and pursuit of our mission has taken a tremendous leap forward,” said Dr. Ikenna Okezie, Chief Executive Officer and Co-Founder of Somatus. “We are grateful to partner alongside Anthem as we, together, continue to improve the lives of so many living with kidney disease.”

About Somatus

Somatus partners with leading health plans, health systems, in addition to nephrology and primary care groups to provide integrated care for patients with, or at risk of developing, kidney disease. As the market leader in value-based kidney care, Somatus' vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia, and founded by a team of world-class healthcare operators, successful entrepreneurs, and leading clinicians treating kidney disease. For more information, please visit www.somatus.com.

About Anthem, Inc.

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 117 million people, including more than 45 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.


ę Business Wire 2021
All news about ANTHEM, INC.
09:16aAnthem President and CEO Gail Boudreaux Named 2022 NCAA Theodore Roosevelt Award Recipi..
BU
01/12Anthem to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January..
BU
01/06Wells Fargo Adjusts Anthem Price Target to $523 From $500, Maintains Overweight Rating
MT
01/05Truist Adjusts Price Target on Anthem to $540 From $490, Maintains Buy Rating
MT
01/05Castlight Health, Vera Whole Health to Merge in $370 Million Deal
MT
01/05Credit Suisse Raises Outperform-Rated Anthem's Price Target to $518 from $486, Remains ..
MT
01/05Castlight Health to Be Acquired by CD&R's Vera for $370 Million
DJ
2021Today on Wall Street: Bad timing
2021ANALYST RECOMMENDATIONS : Anthem, AT&T, Block, Fedex, Visa...
2021Mizuho Securities Upgrades Anthem to Buy From Neutral, Adjusts Price Target to $510 Fro..
MT
More news
Analyst Recommendations on ANTHEM, INC.
More recommendations
Financials (USD)
Sales 2021 138 B - -
Net income 2021 6 117 M - -
Net Debt 2021 16 475 M - -
P/E ratio 2021 18,1x
Yield 2021 1,00%
Capitalization 109 B 109 B -
EV / Sales 2021 0,91x
EV / Sales 2022 0,81x
Nbr of Employees 83 400
Free-Float -
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | ANTM | US0367521038 | MarketScreener
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 448,29 $
Average target price 482,09 $
Spread / Average Target 7,54%
EPS Revisions
Managers and Directors
Gail Koziara Boudreaux President, Chief Executive Officer & Director
John Edward Gallina Chief Financial Officer & Executive Vice President
Elizabeth E. Tallett Independent Chairman
Dustin Wilcox VP & Chief Information Security Officer
Gloria M. McCarthy Chief Administrative Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
ANTHEM, INC.-3.33%108 807
UNITEDHEALTH GROUP-8.19%435 625
CIGNA CORPORATION3.99%79 145
HUMANA INC.-16.38%48 565
CENTENE CORPORATION-5.81%45 286
MOLINA HEALTHCARE, INC.-11.83%16 378